A Study of CDX-0159 in Patients With Prurigo Nodularis

Clinical trial NCT04944862 · COMPLETED

Trial details

NCT number: NCT04944862
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2021-11-08
Primary completion: 2023-07-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.